Cargando…
Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989296/ https://www.ncbi.nlm.nih.gov/pubmed/31876114 http://dx.doi.org/10.1002/ehf2.12522 |
_version_ | 1783492377964445696 |
---|---|
author | Escobar, Carlos Barrios, Vivencio Manzano, Luis |
author_facet | Escobar, Carlos Barrios, Vivencio Manzano, Luis |
author_sort | Escobar, Carlos |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6989296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69892962020-02-03 Switching to sacubitril/valsartan or adding aldosterone antagonist: which first? Escobar, Carlos Barrios, Vivencio Manzano, Luis ESC Heart Fail Correspondence John Wiley and Sons Inc. 2019-12-25 /pmc/articles/PMC6989296/ /pubmed/31876114 http://dx.doi.org/10.1002/ehf2.12522 Text en © 2019 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Correspondence Escobar, Carlos Barrios, Vivencio Manzano, Luis Switching to sacubitril/valsartan or adding aldosterone antagonist: which first? |
title | Switching to sacubitril/valsartan or adding aldosterone antagonist: which first? |
title_full | Switching to sacubitril/valsartan or adding aldosterone antagonist: which first? |
title_fullStr | Switching to sacubitril/valsartan or adding aldosterone antagonist: which first? |
title_full_unstemmed | Switching to sacubitril/valsartan or adding aldosterone antagonist: which first? |
title_short | Switching to sacubitril/valsartan or adding aldosterone antagonist: which first? |
title_sort | switching to sacubitril/valsartan or adding aldosterone antagonist: which first? |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989296/ https://www.ncbi.nlm.nih.gov/pubmed/31876114 http://dx.doi.org/10.1002/ehf2.12522 |
work_keys_str_mv | AT escobarcarlos switchingtosacubitrilvalsartanoraddingaldosteroneantagonistwhichfirst AT barriosvivencio switchingtosacubitrilvalsartanoraddingaldosteroneantagonistwhichfirst AT manzanoluis switchingtosacubitrilvalsartanoraddingaldosteroneantagonistwhichfirst |